Cargando…

Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments

SIMPLE SUMMARY: Personalized neoantigen vaccines are a diverse group of personally tailored cancer vaccines that strengthen patients´ own immune reaction against cancer antigens. We analyzed 147 neoantigen vaccine clinical trials from ClinicalTrials.gov database and showed that peptide vaccines were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemi, Jenni Viivi Linnea, Sokolov, Aleksandr V., Schiöth, Helgi B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600771/ https://www.ncbi.nlm.nih.gov/pubmed/36291947 http://dx.doi.org/10.3390/cancers14205163

Ejemplares similares

Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials
por: Namiot, Eugenia D., et al.
Publicado: (2022)

Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer
por: Lagunas‐Rangel, Francisco Alejandro, et al.
Publicado: (2022)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023)

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials
por: Nazarova, Victoria A., et al.
Publicado: (2022)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy
por: Su, Ting, et al.
Publicado: (2023)

Designing neoantigen cancer vaccines, trials, and outcomes
por: Biswas, Nupur, et al.
Publicado: (2023)

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
por: Bondarev, Andrey D., et al.
Publicado: (2022)

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
por: Rubinsteyn, Alex, et al.
Publicado: (2018)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
por: Li, Lijin, et al.
Publicado: (2021)

Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination—A Retrospective Observation
por: Zelba, Henning, et al.
Publicado: (2022)

Methylation in MAD1L1 is associated with the severity of suicide attempt and phenotypes of depression
por: Sokolov, Aleksandr V., et al.
Publicado: (2023)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022)

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
por: Tang, Lin, et al.
Publicado: (2021)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
por: Wang, Wenwen, et al.
Publicado: (2022)

Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy
por: Su, Ting, et al.
Publicado: (2023)

Personal neoantigen cancer vaccines: The momentum builds
por: Fritsch, Edward F, et al.
Publicado: (2014)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

Personalized cancer neoantigen vaccines come of age
por: Chu, Yanhong, et al.
Publicado: (2018)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Current Trends in Neoantigen-Based Cancer Vaccines
por: Ho, Szu-Ying, et al.
Publicado: (2023)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
por: Morisaki, Shinji, et al.
Publicado: (2023)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
por: van den Ende, Thomas C., et al.
Publicado: (2020)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma
por: Kwak, Larry, et al.
Publicado: (2023)

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
por: Ren, Yingxue, et al.
Publicado: (2020)

Combinatorial Thom-Hirzebruch characteristic classes
por: Teleman, N
Publicado: (1999)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
por: Brown, Scott D., et al.
Publicado: (2018)

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020)

Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)

Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design
por: Hundal, Jasreet, et al.
Publicado: (2017)

Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?
por: Manoutcharian, Karen, et al.
Publicado: (2021)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_icugtbshsglr725qtkif98n74v